Leidsin 17 projekti.
koordinaator-riik [ FI ]
partner-riik [ EE ]
otsingusõna [ Tartu Ülikool ]
|
projekti nr |
akronüüm ja pealkiri |
kestus |
H2020 - 833496
|
BuildERS - Building European Communities' Resilience and Social Capital |
2019-2022 |
H2020 - 679266
|
GRACE - Integrated oil spill response actions and environmental effects |
2016-2019 |
H2020 - 777483
|
ICEDIG - Innovation and consolidation for large scale digitisation of natural heritage |
2018-2020 |
H2020 - 665100
|
MultiCO - Promoting Youth Scientific Career Awareness and it Attractiveness through Multi-stakeholder Co-operation |
2015-2018 |
FP7 - 313010
|
BBMRI-LPC - BBMRI - Large Prospective Cohorts |
2013-2017 |
FP7 - 217889
|
CRISCOMSCORE - Developing a Crisis Communication Scorecard |
2008-2011 |
FP7 - 202063
|
DIABIMMUNE - Pathogenesis of Type 1 Diabetes - Testing the Hygiene Hypothesis |
2008-2013 |
FP7 - 201413
|
ENGAGE - European Network for Genetic and Genomic Epidemiology |
2008-2012 |
FP7 - 213139
|
HYPE - High efficiency consolidated bioprocess technology for lignocellulose ethanol |
2008-2012 |
FP6 - 037651
|
EPIVAC - Development of multi-step improved epidermis-specific vaccine candidate against HIV1/AIDS |
2007-2009 |
FP6 - 036833
|
EUCAARI - European Integrated project on Aerosol Cloud Climate and Air Quality interactions |
2007-2010 |
FP6 - 505906
|
NENA - Nanostructures for Energy and Chemicals Production |
2004-2007 |
FP5 - 67443
|
CAREKEYS - Keys for quality performance management of the care of older persons in Europe |
2003-2006 |
FP5 - 57351
|
CEI - Churches and European Integration |
2001-2004 |
FP5 - 54604
|
CYSTATIN B IN EPILEP - Progressive Myoclonic Epilepsy and Neural Apoptsis. A Genetic, Molecular, biological, biochemical and Pharmacological Approach to Cystatin B and Cystein Protease |
2001-2004 |
FP5 - 61230
|
DANLIM - Detection and analysis of nutrient limitation in coastal plankton communities across a hierarchy of temporal and physiological-systemic scales |
2002-2004 |
FP5 - 62853
|
DIABETES PREVENTION - Nutritional primary prevention of type 1 diabetes |
2002-2006 |
|
|